Intravitreal triamcinolone acetonide may increase the intraocular pressure even in vitrectomized eyes after more than 3 months [2] (multiple letters)

American Journal of Ophthalmology

Volumn 140, Issue 4, 2005, Pages 766-767

  Meyer, Carsten H ^a   Mennel, Stefan ^a   Schmidt, Jörg C ^a   Inoue, Makoto ^a   Ohtake, Yuichiro ^a   Shinoda, Kei ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

CLINICAL TRIAL; DRUG CLEARANCE; HALF LIFE TIME; HUMAN; INTRAOCULAR PRESSURE; LETTER; NONHUMAN; PHACOEMULSIFICATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA EDEMA; SUBRETINAL NEOVASCULARIZATION; VITRECTOMY;

EID: 26844479608     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.02.046     Document Type: Letter

References (6)

1. M. Inoue K. Takeda K. Morita Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection Am J Ophthalmol 138 2004 1046 1048
2. R.H. Schindler D. Chandler R. Thresher R. Machemer The clearance of intravitreal triamcinolone acetonide Am J Ophthalmol 93 1982 415 417
3. P.M. Beer S.J. Bakri R.J. Singh Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 2003 681 686
4. J.B. Jonas Intraocular availability of triamcinolone acetonide after intravitreal injection Am J Ophthalmol 137 2004 560 562
5. J.B. Jonas R.F. Degenring B.A. Kamppeter Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema Am J Ophthalmol 138 2004 158 160
6. S. Agrawal J. Agrawal T.P. Agrawal Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide Am J Ophthalmol 138 2004 679 680